Insider Selling: Imagin Medical Inc (IME) Director Sells 100,000 Shares of Stock

Imagin Medical Inc (CNSX:IME) Director William Clayton Galine sold 100,000 shares of the company’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of C$0.37, for a total value of C$37,000.00.

William Clayton Galine also recently made the following trade(s):

  • On Friday, January 26th, William Clayton Galine sold 25,000 shares of Imagin Medical stock. The stock was sold at an average price of C$0.37, for a total value of C$9,250.00.
  • On Tuesday, December 5th, William Clayton Galine bought 177,671 shares of Imagin Medical stock. The stock was bought at an average price of C$0.12 per share, for a total transaction of C$21,320.52.
  • On Friday, December 1st, William Clayton Galine sold 50,000 shares of Imagin Medical stock. The stock was sold at an average price of C$0.24, for a total value of C$12,000.00.

Shares of Imagin Medical Inc (IME) traded down C$0.02 during mid-day trading on Friday, reaching C$0.37. The company’s stock had a trading volume of 2,160,000 shares. The stock has a market capitalization of $30.17 and a P/E ratio of -12.17. Imagin Medical Inc has a 52 week low of C$0.05 and a 52 week high of C$0.44.

ILLEGAL ACTIVITY WARNING: “Insider Selling: Imagin Medical Inc (IME) Director Sells 100,000 Shares of Stock” was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/26/insider-selling-imagin-medical-inc-ime-director-sells-100000-shares-of-stock.html.

Receive News & Ratings for Imagin Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imagin Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply